It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use ...

The US Food and Drug Administration plans to cut the time it takes drug companies to test new medicines by getting more ...

Researchers at Kent have established a computational protocol that could accelerate the development of more effective ...

U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...

Texas leaders' push for an ibogaine drug spurs concern that they're looking to bigfoot their way into a research ecoysystem ...

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, today announced it has selected ...

Malaria is a major global health problem. The therapeutic options are scarce and challenged by the emergence of resistant parasite strains, which causes a ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

The global antibody drug conjugate (ADC) market size was valued at USD 13.51 billion in 2025 and is predicted to hit around ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...